@article{TLCR23598,
author = {Umberto Malapelle and Antonino Iaccarino and Antonio Rossi},
title = {Cytology versus histology for programmed death-ligand 1 expression evaluation in the landscape of non-small cell lung cancer patients selection for immunotherapy},
journal = {Translational Lung Cancer Research},
volume = {7},
number = {Suppl 3},
year = {2018},
keywords = {},
abstract = {Programmed death 1 (PD-1)/programmed death-ligand 1 (PD-L1) represent key targets for specific monoclonal antibody inhibitors, such as pembrolizumab, nivolumab and atezolizumab, currently used in clinical practice for the management of metastatic non-small cell lung cancer (NSCLC) patients (1).},
issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/23598}
}